Discover Professional Aesthetic Solutions and Build New Partnerships in the Middle East
Dubai Derma 2026 will bring the global dermatology and aesthetics community together in Dubai from September 8–10, 2026. BS PHARM KOREA will participate in this major international event to showcase its professional aesthetic portfolio. In addition, we will connect with distributors, business partners, and industry professionals from around the world.
Dubai Derma is a major international platform for dermatology, aesthetics, and related technologies. Therefore, the event provides an important opportunity to build new connections across the Middle East and international markets.
Visitors can meet our team and discover featured solutions including INHILO+, NAD PRO+, and PLLACELL, along with EVErECM, our new organoid ECM-based solution making its exhibition debut at Dubai Derma 2026.
- – Dubai Derma 2026
- Date: September 8–10, 2026
- Venue: Dubai World Trade Centre, UAE
- BS PHARM KOREA Booth No: Zabeel Hall3, Stand Z2F12
Dubai Derma 2026 Returns to Dubai This September
The 25th edition of Dubai Derma 2026 will take place from September 8–10 at the Dubai World Trade Centre.
Originally scheduled for spring 2026, the event was rescheduled to September. According to the official organizer, the decision considered the interests of exhibitors, sponsors, visitors, speakers, and delegates. As a result, the new schedule is designed to support strong participation and the continued success of the event.
With the new dates confirmed, BS PHARM KOREA looks forward to meeting distributors, partners, and industry professionals in Dubai this September.
Why Dubai Derma Is a Major Global Aesthetic Event
Dubai Derma provides an international platform connecting the dermatology and aesthetic industry with markets across the Middle East and beyond.
The scale of the event can be seen in the official Dubai Derma 2025 Post Show Report, which highlights the event’s international reach and industry participation.
- – 25,000+ Visitors & Participants
- – 114 Participating Countries
- – 1,875 International Brands
- – 500+ Exhibiting Companies
In addition, the 2025 edition covered more than 30,900 sqm of exhibition space. The event brought together companies, professionals, distributors, and technologies from across the global dermatology and aesthetics industry
Overall, these figures show the scale and international reach of Dubai Derma. The event provides opportunities to discover new solutions, exchange market insights, and build business connections.
Why Dubai Derma 2026 Matters for the Middle East Market
For BS PHARM KOREA, the regional profile of Dubai Derma makes the event particularly relevant to our global partnership strategy.
According to the Dubai Derma 2025 Post Show Report, 50% of participants came from GCC countries. In addition, 20% came from the rest of the Middle East and Africa, while 11% came from Central Asia.
Importantly, distributors represented 29% of participants. This highlights Dubai Derma’s strong B2B relevance. Aesthetic practitioners and clinics accounted for 32%, while dermatologists represented 27%.
For BS PHARM KOREA, these markets are an important focus for international business development. Therefore, our main goal at Dubai Derma 2026 is to connect with new distributors across the GCC. We will also explore opportunities across the wider Middle East, Africa, and Central Asia.
Our participation reflects a broader goal: connecting professional Korean aesthetic solutions with international markets through sustainable business partnerships.
Discover Our Featured Solutions at Dubai Derma 2026
At Dubai Derma 2026, BS PHARM KOREA will present a selection of professional aesthetic solutions representing different formulation technologies and aesthetic concepts. The exhibition will also mark the debut of EVErECM, our newly introduced organoid ECM-based solution.
INHILO+
A dual-molecular HA skin booster formulated with H-HA 24 mg + L-HA 24 mg, developed around hydration, skin quality, and natural lifting concepts.
NAD PRO+
An NAD⁺-based professional aesthetic solution developed around emerging approaches to skin quality and professional aesthetic care.
PLLACELL
A PLLA-based aesthetic solution featuring a multi-ingredient formulation for professional aesthetic applications.
NEW PRODUCT DEBUT — EVErECM
EVErECM will make its exhibition debut at Dubai Derma 2026. It is BS PHARM KOREA’s new organoid ECM-based solution, developed around an extracellular matrix approach to skin quality and remodeling.
Together, these products highlight the diverse technologies in the BS PHARM KOREA portfolio. They also allow international partners to explore different aesthetic concepts for their markets. In particular, Dubai Derma 2026 will mark the exhibition debut of EVErECM, one of the latest additions to our portfolio.
Meet BS PHARM KOREA at Dubai Derma 2026
BS PHARM KOREA will welcome visitors at Zabeel Hall3, Stand Z2F12 throughout Dubai Derma 2026.
At our stand, visitors can discover our featured aesthetic solutions and meet our team directly. In addition, they can discuss distribution and partnership opportunities for their markets.
- Visit BS PHARM KOREA
- September 8–10, 2026
- Dubai World Trade Centre, UAE
- Zabeel Hall3, Stand Z2F12
Whether you are an existing partner or exploring professional Korean aesthetic solutions for your market, we look forward to meeting you in Dubai.
Schedule a Meeting at Dubai Derma 2026
Are you planning to attend Dubai Derma 2026?
Schedule a meeting with the BS PHARM KOREA team to discuss distribution opportunities, professional aesthetic solutions, and potential partnerships in your market.
Our main focus is to expand our distributor network across the GCC. We will also explore new opportunities across the wider Middle East, Africa, and Central Asia. Ultimately, Dubai Derma 2026 provides an important opportunity to build new connections and explore long-term collaboration.
